XMD17-109

CAT: 0804-HY-15665-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-15665-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
XMD17-109 is a novel, specific ERK-5 inhibitor, with an IC50 of 162 nM.
CAS Number
[1435488-37-1]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xmd17-109.html
Concentration
10mM
Purity
99.20
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C2=C(C=CC=C2)N(C3CCCC3)C4=NC(NC5=C(OCC)C=C(C(N6CCC(N7CCN(C)CC7)CC6)=O)C=C5)=NC=C4N1C
Molecular Formula
C36H46N8O3
Molecular Weight
638.80
Precautions
H315, H319
References & Citations
[1]Deng X, et al. Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6 (11H) -ones. Eur J Med Chem. 2013;70:758-67.|[2]Elkins, Jonathan M., et al. X-ray Crystal Structure of ERK5 (MAPK7) in Complex with a Specific Inhibitor. Journal of Medicinal Chemistry (2013), 56 (11), 4413-4421.|[3]Wilhelmsen K, et al. Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation. Sci Signal. 2015 Aug 25;8 (391) :ra86.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERK5

Related Products

CatalogName
HY-18619-01YL-109
HY-11046AKRP-109
HY-114116-01ML-109
HY-W423595-01BEBT-109
HY-162360EGFR-IN-109
HY-135307-01SSF-109
HY-19643JTK-109
HY-118833RAC 109
HY-129603-01SI-109
HY-147835Antibacterial agent 109

Alternative Products

CatalogName
MBS130327-01XMD17-109
M21973-01ML-109
MBS5767606SI-109
MBS575722YL-109
MBS5775763RAC 109
bs-83459C-01DT-109
sc-52431RhC (109)
202841TAS-109
464661-01RGFP 109

Popular Products